Predicting 1p19q Chromosomal Deletion of Low-Grade Gliomas from MR Images using Deep Learning

Zeynettin Akkus, Issa Ali, Jirí Sedlár, Timothy L. Kline, Jay P. Agrawal, Ian F. Parney, Caterina Giannini, Bradley J. EricksonarXiv 2016 · arXiv

Introduction

Low-grade gliomas (LGG) represent a diverse group of primary brain tumors where treatment strategies are heavily influenced by genetic markers. A primary biomarker is the "1p/19q codeletion"—the simultaneous loss of the short arm of chromosome 1 and the long arm of chromosome 19. Patients harboring this deletion typically exhibit superior responses to chemotherapy and longer overall survival.

Currently, determining 1p/19q status requires invasive surgical biopsy followed by laboratory techniques such as fluorescence in situ hybridization (FISH). These procedures carry inherent surgical risks and may suffer from sampling bias. This research presents a deep learning-based, non-invasive alternative that predicts genetic status directly from routine magnetic resonance imaging (MRI).

Methods and Architecture

The core of the proposed solution is a specialized multi-scale Convolutional Neural Network (CNN) designed to extract features across various spatial dimensions.

Preprocessing

The pipeline begins with the registration of T1-weighted post-contrast (T1C) and T2-weighted images to ensure spatial alignment. Semi-automated segmentation is used to define the tumor region of interest (ROI), and "skull-stripping" removes non-brain tissue to reduce noise.

Multi-Scale CNN Design

Unlike traditional CNNs that utilize uniform filter sizes, this architecture employs multiple parallel branches. These branches use filters ranging from 10x10 to 200x200 pixels. This design allows the network to simultaneously analyze fine-grained local textures (the "trees") and broader global tumor morphology (the "forest").

Data Augmentation

To address the challenge of limited medical data, the researchers applied aggressive 30-fold data augmentation. By randomly rotating, flipping, and shifting the 477 available image slices, the model was trained to recognize invariant features, significantly reducing the risk of overfitting.

Dataset and Results

The study utilized a retrospective dataset from the Mayo Clinic involving 159 LGG patients (102 non-deleted, 57 codeleted). The model was trained on three slices per patient: the tumor equator and the slices immediately above and below.

The optimal configuration, utilizing both T1C and T2 sequences combined with 30-fold augmentation, achieved the following performance on an independent test set:

  • Overall Accuracy: 87.7%
  • Sensitivity: 93.3%
  • Specificity: 82.2%

These results significantly outperform traditional radiomic approaches, which typically rely on hand-crafted features and often struggle to exceed 70% accuracy.

Discussion and Future Directions

The success of the multi-scale architecture suggests that the 1p/19q genetic signature manifests in both the macro-structure of the tumor and the subtle pixel-level variations of the tissue. Furthermore, the superior performance of the multi-modal (T1C + T2) model indicates that genetic information is distributed across different physical properties captured by varying MRI sequences.

Limitations

Despite its high accuracy, the study has limitations. The current model operates on 2D slices; transitioning to 3D CNNs could provide a more comprehensive spatial context. Additionally, the model was trained against FISH results, which have a baseline error rate of 5-12%, potentially capping the theoretical maximum accuracy of any supervised model. Future work will focus on validating these findings across larger, multi-institutional datasets and improving model interpretability for clinical use.

Summary updated

Abstract

Objective: Several studies have associated codeletion of chromosome arms 1p/19q in low-grade gliomas (LGG) with positive response to treatment and longer progression free survival. Therefore, predicting 1p/19q status is crucial for effective treatment planning of LGG. In this study, we predict the 1p/19q status from MR images using convolutional neural networks (CNN), which could be a noninvasive alternative to surgical biopsy and histopathological analysis. Method: Our method consists of three main steps: image registration, tumor segmentation, and classification of 1p/19q status using CNN. We included a total of 159 LGG with 3 image slices each who had biopsy-proven 1p/19q status (57 nondeleted and 102 codeleted) and preoperative postcontrast-T1 (T1C) and T2 images. We divided our data into training, validation, and test sets. The training data was balanced for equal class probability and then augmented with iterations of random translational shift, rotation, and horizontal and vertical flips to increase the size of the training set. We shuffled and augmented the training data to counter overfitting in each epoch. Finally, we evaluated several configurations of a multi-scale CNN architecture until training and validation accuracies became consistent. Results: The results of the best performing configuration on the unseen test set were 93.3% (sensitivity), 82.22% (specificity), and 87.7% (accuracy). Conclusion: Multi-scale CNN with their self-learning capability provides promising results for predicting 1p/19q status noninvasively based on T1C and T2 images. Significance: Predicting 1p/19q status noninvasively from MR images would allow selecting effective treatment strategies for LGG patients without the need for surgical biopsy.
BibTeX
@misc{akkus2016predicting,
  author = {Zeynettin Akkus and Issa Ali and Jirí Sedlár and Timothy L. Kline and Jay P. Agrawal and Ian F. Parney and Caterina Giannini and Bradley J. Erickson},
  title = {{Predicting 1p19q Chromosomal Deletion of Low-Grade Gliomas from MR Images using Deep Learning}},
  year = {2016},
  eprint = {1611.06939},
  archivePrefix = {arXiv},
  url = {https://arxiv.org/abs/1611.06939},
}
Figure